The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people around the world suffer from long COVID-19.
CHARLOTTESVILLE – UVA Health researchers have discovered a potential way to predict which patients with severe COVID-19 are likely to recover well and which are likely to suffer “long-haul” lung ...
LUBBOCK, Texas. - A Texas doctor is noticing a pattern in her patients that could reveal another possible devastating side effect of COVID-19: severely scarred lungs. Dr. Brittany Bankhead-Kendall, a ...
When breathing becomes increasingly difficult with no clear explanation, idiopathic pulmonary fibrosis (IPF) might be the culprit behind the concerning symptoms. This rare yet devastating lung disease ...
BirchBioMed Inc., a leading clinical stage biopharmaceutical company, expert in the development of products for scarring and other fibrosis-related disorders and autoimmune therapeutics, today ...
NEW YORK -- Rescue workers and firefighters contracted a serious lung-scarring disease called sarcoidosis at a much higher rate after the Sept. 11, 2001, attacks than before, said a study that is the ...
Pulmonary fibrosis—also known in technical terms as idiopathic pulmonary fibrosis (IPF)—is a rare but life-threatening ...
Pulmonary sarcoidosis is a condition that causes tiny groups of immune cells to clump in your lungs. These groups of cells form swollen, inflamed lumps called granulomas. Granulomas can make it hard ...
Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback